Skip to content

Research at St Andrews

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

Research output: Contribution to journalArticle



Rona Ruth Ramsay, C Dunford, P.K. Gillman

School/Research organisations


Background and purpose: Monoamine oxidase inhibitors (MAOI) are known to cause serotonin toxicity (ST) when administered with selective serotonin reuptake inhibitors (SSRI). Methylene blue (methylthionium chloride, MB), a redox dye in clinical use, has been reported to precipitate ST in patients using SSRI. MB was assessed for MAO inhibition and so for its potential to precipitate ST.

Experimental approach: Inhibition of purified human MAO was quantified using kinetic assays and visible spectral changes to study the interactions of MB with MAO A.

Key results: MB was a potent (tight binding) inhibitor for MAO A. It also inhibited MAO B but at much higher concentration. Interactions of MB with the active site of MAO A were confirmed by its action both as an oxidising substrate and as a one-electron reductant.

Conclusions and implications: MB is a potent reversible inhibitor of MAO A with implications for gut uptake of amines when administered orally. At concentrations reported in the literature after intravenous administration, MAO B would be partially inhibited but MAO A would be completely inhibited. This inhibition of MAO A would be expected to lead to perturbations of 5-hydroxytryptamine metabolism and hence account for ST occurring when administered to patients on SSRI treatment.



Original languageEnglish
Pages (from-to)946-951
Number of pages6
JournalBritish Journal of Pharmacology
Issue number6
StatePublished - Nov 2007

    Research areas

  • methylene blue, methylthionium chloride, serotonin toxicity, monoamine oxidase A, MAOI, tight binding, IFOSFAMIDE ENCEPHALOPATHY, REVERSIBLE INHIBITION, MECHANISM, OXIDATION, FLUORESCENCE, KINETICS, ANALOGS, MONOMER, BINDING

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Kinetics, mechanism and inhibition of monoamine oxidase

    Ramsay, R. R. & Albreht, A. Nov 2018 In : Journal of Neural Transmission. 125, 11, p. 1659–1683 25 p.

    Research output: Contribution to journalReview article

  2. Evidence for a cyanine link between propargylamine drugs and monoamine oxidase clarifies the inactivation mechanism

    Albreht, A., Vovk, I., Mavri, J., Marco-Contelles, J. & Ramsay, R. R. 28 May 2018 In : Frontiers in Chemistry. 6, 11 p., 169

    Research output: Contribution to journalArticle

  3. A perspective on multi-target drug discovery and design for complex diseases

    Ramsay, R. R., Popovic-Nikolicb, M. R., Nikolic, K., Uliassi, E. & Bolognesi, M. L. 17 Jan 2018 In : Clinical and Translational Medicine. 7, 14 p., 3

    Research output: Contribution to journalReview article

  4. Multitarget-directed ligands combining cholinesterase and monoamine oxidase inhibition with histamine H3R antagonism for neurodegenerative diseases

    Bautista-Aguilera, Ó. M. , Hagenow, S. , Palomino-Antolin, A. , Farré-Alins, V. , Ismaili, L. , Joffrin, P-L. , Jimeno, M. L. , Soukup, O. , Janočková, J. , Kalinowsky, L. , Proschak, E. , Iriepa, I. , Moraleda, I. , Schwed, J. S. , Romero Martínez, A. , López-Muñoz, F. , Chioua, M. , Egea, J. , Ramsay, R. R. , Marco-Contelles, J. & 1 others Stark, H. 2 Oct 2017 In : Angewandte Chemie International Edition. 56, 41, p. 12765–12769 5 p., 201706072R2

    Research output: Contribution to journalArticle

  5. Assessment of enzyme inhibition: a review with examples from the development of monoamine oxidase and cholinesterase inhibitory drugs

    Ramsay, R. R. & Tipton, K. F. Jul 2017 In : Molecules. 22, 7, 46 p., 1192

    Research output: Contribution to journalReview article

Related by journal

  1. Updating neuropathology and neuropharmacology of monoaminergic systems

    Ramsay, R. R., De Deurwaerdère, P. & Di Giovanni, G. Jul 2016 In : British Journal of Pharmacology. 173, 13, p. 2065-2068 4 p.

    Research output: Contribution to journalEditorial

  2. GABAB receptor subtypes differentially modulate synaptic inhibition in the dentate gyrus to enhance granule cell output

    Foster, J. D., Kitchen, I., Bettler, B. & Chen, Y. 1 Apr 2013 In : British Journal of Pharmacology. 168, 8, p. 1808-1819

    Research output: Contribution to journalArticle

  3. Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals

    Miller, JC., Howson, PA., Conway, S. J., Williams, RV., Clark, BP. & Jane, DE. Aug 2003 In : British Journal of Pharmacology. 139, p. 1523-1531 9 p.

    Research output: Contribution to journalArticle

  4. A direct inhibitory action of prostaglandins upon ACTH secretion at the late stages of the secretory pathway of AtT-20 cells

    Wilson, ML. & Guild, S. Apr 2002 In : British Journal of Pharmacology. 135, 8, p. 1851-1858 8 p.

    Research output: Contribution to journalArticle

ID: 379328